Nkarta (NKTX) Stock: Buy, Sell, or Hold?
NKTX - Nkarta, Inc. Common Stock
$1.74
-0.01 (-0.57%)
▼
5d:
-9.84%
30d:
-36.96%
90d:
-23.35%
HOLD
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 09, 2026
16d
Get Alerted When NKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NKTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NKTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NKTX is currently trading at $1.74, which is considered oversold relative to its 30-day fair value range of $2.01 to $2.83.
Technical Outlook: Technically, NKTX is in a downtrend. The price is currently testing key support at $1.72. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NKTX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.83 (+522.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NKTX is in a downtrend. The price is currently testing key support at $1.72. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NKTX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $10.83 (+522.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.01 -
$2.83
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 522.6% below Wall St target ($10.83)
- CAUTION: Bottoming setup, but lagging the sector by 26% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-9.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.01 -
$2.83
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.72
Resistance Level
$2.31
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.99
Wall Street Target
$10.83
(+522.6%)
Share & Embed Analysis
Last updated: October 23, 2026 4:40 AM ET
Data refreshes hourly during market hours. Next update: 5:40 AM
Data refreshes hourly during market hours. Next update: 5:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NKTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$295 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$864 | 44 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
20 analysts |
$650 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$36 | 57 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 66 BUY |
